Our first post market clinical study V.A.S.C. continues at the Policlinico San Donato IRCCS as the coordinating center, under the supervision of our P.I. Paolo Righini (MD) and the Department of Vascular Surgery directed by Prof. Giovanni Nano.
On April 12th, 2023, the first two EVA (Empty Vein Ablation) procedures were completed using our device VELEX™, at the San Rafafele IRCCS of Milan, which is the other center participating in this study and part of the San Donato Group.
We would like to thank Domenico Baccellieri MD, director of the Vein Center at the San Raffaele Hospital, and his talented team, including Carlotta Bugna MD, as well as the Operative Unit of vascular surgery directed by Prof. Roberto Chiesa.
This surely is another important milestone throughout I-VASC’s journey which aims for bringing VELEX™ and EVA (Empty Vein Ablation) technology to the global market.